(-0.04%) 5 305.93 points
(0.00%) 39 909 points
(-0.08%) 16 729 points
(0.79%) $79.25
(3.06%) $2.49
(-0.40%) $2 385.30
(0.56%) $29.90
(-0.09%) $1 069.10
(0.16%) $0.920
(0.27%) $10.69
(0.08%) $0.789
(0.16%) $90.83
Live Chart Being Loaded With Signals
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology...
Stats | |
---|---|
Today's Volume | 7 398.00 |
Average Volume | 82 813.00 |
Market Cap | 7.95M |
EPS | £0 ( 2024-05-15 ) |
Next earnings date | ( £0 ) 2024-08-14 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -0.230 |
ATR14 | £0.0390 (1.03%) |
Volume Correlation
NuCana PLC Correlation
10 Most Positive Correlations | |
---|---|
ARVL | 0.89 |
ATRC | 0.887 |
SQL | 0.884 |
ARIZ | 0.868 |
MBIO | 0.867 |
PDSB | 0.864 |
EZGO | 0.86 |
FIVE | 0.857 |
AMRS | 0.853 |
VWE | 0.851 |
10 Most Negative Correlations | |
---|---|
MOTNU | -0.892 |
NN | -0.889 |
LWAY | -0.886 |
CENX | -0.885 |
QRHC | -0.869 |
CURI | -0.868 |
GRIN | -0.862 |
PPTA | -0.86 |
SMTC | -0.86 |
DBDR | -0.856 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NuCana PLC Correlation - Currency/Commodity
NuCana PLC Financials
Annual | 2023 |
Revenue: | £0 |
Gross Profit: | £0 (0.00 %) |
EPS: | £-0.520 |
FY | 2023 |
Revenue: | £0 |
Gross Profit: | £0 (0.00 %) |
EPS: | £-0.520 |
FY | 2022 |
Revenue: | £0 |
Gross Profit: | £0 (0.00 %) |
EPS: | £-0.620 |
FY | 2021 |
Revenue: | £0.00 |
Gross Profit: | £0.00 (0.00 %) |
EPS: | £-0.780 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
NuCana PLC
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and in a Phase 1b/2 clinical trial for patients with advanced colorectal cancer; and NUC-7738, a nucleoside analog that is in Phase 1/2 clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators